Development and clinical evaluation of a microarray for hepatitis C virus genotyping

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 269-275

  Park, Jae Chan ^a,b   Kim, Jong Man ^a   Kwon, Oh Joong ^c   Lee, Kyoung Ryul ^a,c   Chai, Young Guy ^b   Oh, Heung Bum ^d  

^a BioCore Institute of Biotechnology   (South Korea)

^b Hanyang University   (South Korea)

^c Seoul Medical Science Institute   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

5 UTR; HCV genotyping; Oligonucleotide DNA chip

Indexed keywords

CYANINE DYE 3; STREPTAVIDIN;

5' UNTRANSLATED REGION; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DNA DENATURATION; DNA HYBRIDIZATION; DNA MICROARRAY; DNA SEQUENCE; FRANCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; KOREA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS IDENTIFICATION;

FRANCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MICROARRAY ANALYSIS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPUBLIC OF KOREA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SERUM; STATISTICS AS TOPIC; VIROLOGY;

HEPATITIS C VIRUS;

EID: 73249152960     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.10.008     Document Type: Article

References (30)

1. Ansaldi F., Torre F., Bruzzone B.M., Picciotto A., Crovari P., and Icardi G. Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping. J. Med. Virol. 63 (2001) 17-21
2. Bukh J., Miller R.H., and Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotype. Semin. Liver Dis. 15 (1995) 41-63
3. Cantaloube J.F., Laperche S., Gallian P., Bouchardeau F., de Lamballerie X., and de Micco P. Analysis of the 5′ noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J. Clin. Microbiol. 44 (2006) 2051-2061
4. Chan S.W., McOmish F., Holmes E.C., Dow B., Peutherer J.F., Follett E., Yap P.L., and Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73 (1992) 1131-1141
5. Chen Z., and Weck K.E. Hepatitis C virus genotyping: interrogation of the 5′untranslated region cannot accurately distinguish genotypes 1a and 1b. J. Clin. Microbiol. 40 (2000) 3127-3134
6. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradly D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
7. Dixit V., Quan S., Martin P., Larson D., Brezina M., DiNello R., Sra K., Lau J.Y., Chien D., Kolberg J., Tagger A., Davis G., Polito A., and Gitnick G. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J. Clin. Microbiol. 33 (1995) 2978-2983
8. Farrell G.C. New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J. Gastroenterol. Hepatol. 22 (2007) 607-610
9. Ferenci P. Peginterferon alfa-2a (40 kD) (Pegasys) for the treatment of patients with chronic hepatitis C. Int. J. Clin. Pract. 57 (2003) 610-615
10. Fried M.W. Clinical application of hepatitis C virus genotyping and quantitation. Clin. Liver Dis. 1 (1997) 631-646
11. Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer Jr. H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P.J., Lin A., and Ackrill A.M. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140 (2004) 346-355
12. Han C.J., Lee H.S., Kim H.S., Choe J.H., and Kim C.Y. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases. Kor. J. Intern. Med. 12 (1997) 21-27
13. Hnatyszyn H.J. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir. Ther. 10 (2005) 1-11
14. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Sugimura T., and Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9524-9528
15. Miller R.H., and Purcell R.H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 2057-2061
16. Murphy D.G., Willems B., Deschenes M., Hilzenrat N., Mousseau R., and Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′untranslated region sequences. J. Clin. Microbiol. 45 (2007) 1102-1112
17. National Institute for Health and Clinical Excellence, 2004. Interferon alfa (pegylated and non pegylated) and ribavirin for the treatment of chronic hepatitis C. NICE technology appraisal no. 75, http://www. nice.org.uk/Guidance/TA75/Guidance/pdf/English.
18. Nolte F.S., Green A.M., Fiebelkorn K.R., Caliendo A.M., Sturchio C., Grunwald A., and Healy M. J. Clin. Microbiol. 41 (2003) 1558-1564
19. Park Y.S., Lee K.O., Oh M.J., and Chai Y.G. Distribution of genotypes in the 5′ untranslated region of hepatitis C virus in Korea. J. Med. Microbiol. 47 (1998) 643-647
20. Park H., Jang H., Song E., Chang C.L., Lee M., Jeong S., Park J., Kang B., and Kim C. Detection and genotyping of mycobacterium species from clinical isolates and specimens by oligonucleotide array. J. Clin. Microbiol. 43 (2005) 1782-1788
21. Schena M. Microarray Analysis (2003), John Wiley & Sons Inc., Hoboken, NJ
22. Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., Beall E., Yap P.L., Kolberg J., and Urdea M.S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74 (1993) 2391-2399
23. Simmonds P., McOmish F., Yap P.L., Chan S.W., Lin C.K., Dusheiko G., Saeed A.A., and Holmes E.C. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J. Gen. Virol. 74 (1993) 661-668
24. Simmonds P. Variability of hepatitis C virus genome. Curr. Stud. Hematol. Blood Transfus. 61 (1994) 12-35
25. Smith D.B., Mellor J., Jarvis L.M., Davision F., Kolberg J., Urdea M., Yap P.L., and Simmonds P. Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing. J. Gen. Virol. 76 (1995) 1749-1761
26. Soriano V., Peters M.G., and Zeuzem S. New therapies for hepatitis C virus infection. Clin. Infect. Dis. 48 (2009) 313-320
27. Stuyver L., Wyseur A., van Aruhem W., Lunel F., Laurent-Puig P., Pawlotsky J.M., Kleter B., Bassit L., Nkengasong J., van Doorn L.J., and Maertens G. Hepatitis C virus genotyping by means of 5′UR/core line probe assay and molecular analysis of untypeable samples. Virus Res. 38 (1995) 137-157
28. Takada N., Takase S., Takada A., and Date T. Differences in the hepatitis C virus genotypes in different countries. J. Hepatol. 17 (1993) 277-283
29. Young K.K., Resnick R.M., and Myers T.W. Detection of hepatitis C virus RNA by combined reverse transcription-polymerase chain assay. J. Clin. Microbiol. 31 (1993) 882-886
30. Zein N.N. Clinical significance of hepatitis c virus genotypes. Clin. Microbiol. Rev. 13 (2000) 223-235